Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2018-12-22
Date Granted : 2010-02-09
Brand Name : NEXAVAR
Patent Number : 2315646
Filing Date : 1998-12-22
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2010-02-09
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2020-01-12
Date Granted : 2007-02-13
Brand Name : NEXAVAR
Patent Number : 2359510
Filing Date : 2000-01-12
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-01-12
Date Granted : 2007-02-13
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2025-09-20
Date Granted : 2012-05-15
Brand Name : NEXAVAR
Patent Number : 2581843
Filing Date : 2005-09-20
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-09-20
Date Granted : 2012-05-15
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2024-05-19
Date Granted : 2017-09-05
Brand Name : NEXAVAR
Patent Number : 2526636
Filing Date : 2004-05-19
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-05-19
Date Granted : 2017-09-05
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2018-12-22
Date Granted : 2010-06-22
Brand Name : NEXAVAR
Patent Number : 2315715
Filing Date : 1998-12-22
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2010-06-22
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2026-02-22
Date Granted : 2012-07-10
Brand Name : NEXAVAR
Patent Number : 2601955
Filing Date : 2006-02-22
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-02-22
Date Granted : 2012-07-10
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2020-01-13
Date Granted : 2013-10-08
Brand Name : NEXAVAR
Patent Number : 2359244
Filing Date : 2000-01-13
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-01-13
Date Granted : 2013-10-08
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2024-05-19
Date Granted : 2015-04-28
Brand Name : NEXAVAR
Patent Number : 2526617
Filing Date : 2004-05-19
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-05-19
Date Granted : 2015-04-28
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2023-02-11
Date Granted : 2016-12-20
Brand Name : NEXAVAR
Patent Number : 2475703
Filing Date : 2003-02-11
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-02-11
Date Granted : 2016-12-20
